Security Snapshot

GOSSAMER BIO INC - NOTE 5.000% 6/0 Institutional Ownership

CUSIP: 38341PAA0

13F Institutional Holders and Ownership History from Q2 2020 to Q2 2026

Latest Period

Q1 2026

Institutions Reporting

11

Principal

$202,406,000

Price (% of par)

40.0%

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Principal change
+$16,775,000
Market value change
-$6,104,627
Number of holders
11
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • 38341PAA0 - GOSSAMER BIO INC - NOTE 5.000% 6/0 is tracked under CUSIP 38341PAA0.
  • 11 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 11 to 0 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $80,815,511 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 11 institutions filings for Q1 2026.

Open SEC evidence

Security key

38341PAA0

Latest holder period

Q1 2026

13F holders

11

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 11 institutional investors reported holding $202,406,000 in principal (par value) of GOSSAMER BIO INC - NOTE 5.000% 6/0.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
25
Latest
Q1 2026
Rows shown
1-25 of 25
Period Principal Value Change Price (% of par) (Median) Investors
2026 Q2 $0 $0 -$20,017,679 0
2026 Q1 $202,406,000 $80,815,511 -$6,104,627 40.0% 11
2025 Q4 $185,631,000 $126,029,478 +$28,975,009 68.06% 14
2025 Q3 $142,653,005 $120,891,211 -$3,070,130 69.5% 15
2025 Q2 $151,898,880 $94,158,395 -$6,577,623 52.47% 13
2025 Q1 $166,276,850 $106,833,547 -$1,128,807 56.0% 13
2024 Q4 $172,449,850 $105,507,106 -$439,375 53.99% 14
2024 Q3 $173,427,850 $91,358,329 -$505,199 52.36% 14
2024 Q2 $174,427,850 $96,670,884 -$752,032 49.14% 14
2024 Q1 $175,927,850 $78,772,359 -$8,738,317,375 40.0% 13
2023 Q4 $188,786,978 $70,928,514 +$7,178,077 37.46% 13
2023 Q3 $169,080,828 $75,590,270 +$418,933 39.61% 14
2023 Q2 $168,582,983 $58,393,690 -$2,952,463 30.65% 14
2023 Q1 $198,268,483 $57,344,867 -$3,104,300 27.59% 18
2022 Q4 $210,389,850 $68,739,390 -$6,327,082 32.35% 18
2022 Q3 $217,354,850 $229,093,000 +$9,445,314 103.25% 23
2022 Q2 $211,054,350 $162,925,000 -$8,295,107 74.75% 21
2022 Q1 $212,217,850 $182,239,000 -$3,082,458 80.87% 23
2021 Q4 $211,455,850 $219,654,000 -$934,561 98.0% 23
2021 Q3 $209,906,850 $217,371,462 +$2,909,827 103.87% 23
2021 Q2 $207,953,250 $167,292,324 +$11,943,418 80.32% 25
2021 Q1 $191,143,250 $172,308,584 -$11,653,434 89.75% 25
2020 Q4 $203,806,000 $185,211,000 -$1,432,829 90.59% 23
2020 Q3 $208,056,000 $214,786,000 +$31,360,555 103.05% 28
2020 Q2 $171,551,000 $172,861,000 +$172,861,000 100.7% 27
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .